Program overview
Context
Indication: Smoldering Multiple Myeloma
Mechanism: Unknown
Modality: Unknown
Sponsor: Lene Meldgaard Knudsen
PD-L1 peptide is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Smoldering Multiple Myeloma
Mechanism: Unknown
Modality: Unknown
Sponsor: Lene Meldgaard Knudsen
Registry: 5/5
Timeline: 1/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 4/5
https://clinicaltrials.gov/study/NCT03850522
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT03850522 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | strict_eligibility_signal |